Dr. Shani Stern (Head of the Precision Disease Modelling Laboratory in the Sagol Department of Neurobiology), is participating in an international effort to find a cure for GRIN2B, an ultra-rare neurodevelopmental disorder. Dr. Stern is developing a biomarker extraction algorithm that will be applied to the GRIN2B cellular models. The effort is being led by Michelle Gauthier and Adam Freed of Ottawa, to help their four-year-old son, Maksim, who suffers from the debilitating disorder. Maksim was accepted into the Israeli study, which aims to develop personalized drug treatments for GRIN2B patients. The sooner the treatment begins, the better the chance of treating Maksim — and possibly reversing the progression of the disease. Maksim’s parents are leading a campaign to raise funds for this research with the assistance of Canadian Friends of Haifa University.
In the News In a landmark investment in Israeli nursing education, the Azrieli Foundation has donated $10 million to establish the Azrieli Advanced Nursing Center
In the News After decades of advocacy the Council for Higher Education has approved the establishment of the University of Haifa’s medical school – a
In the News Over 20 years ago, Michael and Linda Frieze first stepped onto our campus through CJP – the Boston-Haifa Connection – and saw
© University of Haifa Division of External Relations